• Cosmos Health posted record first-quarter revenue of $17.9 million, up 30.7% year over year.
• Net loss widened to $2.81 million, driven mainly by $1.15 million of non-cash, non-operational items including $442,439 of digital-asset mark-to-market losses.
• Total liabilities fell $4.51 million, or 9.6%, to $42.54 million as convertible note and credit facility balances declined.
• Stockholders’ equity rose $1.4 million, or 7.6%, to $19.83 million; cash and cash equivalents totaled $2.2 million.
• Management said momentum continued into Q2 with U.S. expansion underway, targeting entry into the U.S. nutraceuticals market through the 18 Series platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605210915ACCESSWRNAPR_____1169066) on May 21, 2026, and is solely responsible for the information contained therein.